Promis Neurosciences (PMN)Director bought ~$45K

~$45K

Approx. value · 4,000 sh @ $11.33

4,653

Holds after · shares reported

Traded

Apr 22, 2026

Filed

Apr 24, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Feb 19, 2026Insider · Their first buy on recordOfficer purchased ~$25K of PMN shares in the open market
2. Mar 2, 2026Insider · Their largest buy since 2022Director purchased ~$23K of PMN shares in the open market
3. Mar 3, 2026InsiderDirector purchased ~$22K of PMN shares in the open market
4. Mar 4, 2026Insider · Their largest buy since 2022Director purchased ~$48K of PMN shares in the open market
5. Mar 5, 2026InsiderDirector purchased ~$49K of PMN shares in the open market
6. Mar 25, 2026Company filing · Form 8-K · ResultsReported its results
7. Apr 22, 2026 · this disclosureInsider · Their largest buy since 2022Director purchased ~$45K of PMN shares in the open market

What came next

1. May 12, 2026Company filing · Form 8-K · ResultsReported its results
2. May 20, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“As further described in Item 5.07 below, the stockholders of ProMIS Neurosciences Inc. (the “ Company ”) approved an amendment (the “2025 Plan Amendment”) to the Company’s 2025 Stock Option and Incentive Plan (the “ 2025 Plan ”) at the Company’s 2026 Annual Meeting of Stockholders (the “ Annual Meeting ”) held on May 20, 2026.”
3. Aug 5, 2026Insider · 8 days before resultsOfficer purchased ~$30K of PMN shares in the open market
4. Aug 13, 2026Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Promis Neurosciences

For Promis Neurosciences, OQRO holds 1 insider filing (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PMN page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Promis Neurosciences

• SEC Form 4Aug 8, 2026
• SEC Form 4Mar 6, 2026
• SEC Form 4Mar 5, 2026
• SEC Form 4Mar 5, 2026
• SEC Form 4Mar 5, 2026
• SEC Form 4Feb 23, 2026

Everything OQRO holds on this company is on its PMN page.